Loading...
| A00011 | Pages: 238 | Nov 2021 | 22323 Views | | |
| Author(s) : Sushant Terdale, Sanjivan Gill , Onkar Sumant | Tables: 127 | Charts: 42 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Optical Imaging Market
Request Now !Global optical imaging market was valued at $1,386.8 million in 2020, and is projected to reach $3,865.7 million by 2030 registering a CAGR of 10.8% from 2021 to 2030. Optical imaging is the technique for taking images of the internal body parts non-invasively. Visible light and photons are used to take the detailed image of internal organs and tissues. It further captures images of smaller structures includes cells and molecules. These images are used by doctors for diagnosis and treatment of diseases and by scientists for different research work.
The growth of the global optical imaging market is majorly driven by rise in government initiatives to control visual impairment and surge in geriatric population, which is more prone to wide array of diseases such as neurology disorders, ophthalmic conditions, and cardiovascular conditions. In addition, surge in prevalence of eye disorders such as glaucoma and cataract boost the growth of the market. However, lack of access to optical imaging in underdeveloped countries and decrease in demand of optical imaging product, owing to COVID-19 outbreak hamper the growth of market. On the contrary, developing nations show a potential of high growth during forecast period, owing to surge in investments related to healthcare infrastructure and rise in awareness related to optical imaging, which is expected to create opportunity for manufacturers to capitalize in the market.
Get more information on this report : Request Sample Pages
The COVID-19 pandemic surged the need for social distancing among physicians & other healthcare professionals. Owing to COVID-19, many imaging & diagnostic departments have faced a rapid decrease in optical imaging case volumes. The decrease in optical imaging case has significant implications on the short-term & long-term economic stability for all practice settings. For instance, according to a study provided by the Journal of the American College of Radiology (JACR), nearly 28% decrease in the total imaging volume was observed over a seven week-period during this global health crisis, compared to 2019, including all patient service locations & imaging modality types. The impact the pandemic on the optical imaging market is still seen in 2021 as hospitals & imaging facilities strive to manage under the situations of the world slowly reopening post isolation of almost a year. In addition, nonessential imaging procedures were postponed till further notice in almost all countries. Moreover, the key vendors in this market such as Abbott Laboratories, Canon, Koninklijke Philips, Carl Zeiss, and PerkinElmer, Inc. faced severe issues due to mismanagement in the supply chain of their solutions. Thus, decrease in demand for these optical imaging services due to the COVID-19 pandemic negatively impacted the growth of optical imaging market.
The optical imaging market is segmented into product type, therapeutic area, end user, and region. On the basis of product type, the market is divided into imaging systems, illumination systems, camera, software, and lenses. The imaging systems segment is further bifurcated into optical imaging systems and spectral imaging systems. By therapeutic area, the market is segregated into ophthalmology, oncology, cardiology, neurology, others. Depending on end user, it is fragmented into hospitals & clinics, research laboratories and pharmaceuticals & biotechnology companies. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA.
By product type, the imaging systems segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in demand of imaging system, owing to benefits of imaging systems provide over other imaging modalities such as noninvasive nature of optical imaging systems. Furthermore, optical imaging systems significantly reduces patient exposure to harmful radiation. In addition, other factors such as key players are focusing on developing advanced portable devices, which are easier to handle and can be used in various clinical settings. Hence, availability of advanced imaging systems is expected to surge their demand, thereby driving the growth of the market.
On the basis of therapeutic area, the ophthalmology segment exhibited the highest growth in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to extensive application of optical imaging in field of ophthalmology and increase in prevalence of ophthalmic conditions such as macular degeneration and glaucoma, which require the use of optical imaging.
Get more information on this report : Request Sample Pages
Depending on end user, the hospitals & clinics segment acquired the largest share in 2020, and is expected to continue this trend throughout the forecast period. This is attributed to increase in adoption of optical imaging services by hospitals & clinics as they help in diagnosis of various disease conditions.
Region wise, North America acquired a major share, owing to the presence of major key players in the region, which leads to easy availability of optical imaging systems, thereby driving the growth of the market.
Get more information on this report : Request Sample Pages
Asia-Pacific is expected to exhibit the highest growth during the forecast period, owing to number of initiatives and enhanced investments from governments for the overall research and development of advanced optical imaging systems. In addition, rise in applications of optical imaging techniques in drug discovery processes & preclinical research and increase in need of optical imaging to minimize the use of radiation technologies strengthen the growth of the market.
The key market players profiled in the report include Abbott Laboratories, Canon Inc., Carl Zeiss Foundation, Cylite Pty Ltd., Danaher Corporation, Heildelberg Engineering GmbH, Koninklijke Philips N.V., Michelson Diagnostics Ltd., Optovue, Ltd., and Topcon Corporation.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of eye disorders
3.5.1.2.Surge in government initiatives to control visual impairment
3.5.1.3.Increase in geriatric population
3.5.2.Restraint
3.5.2.1.Lack of access to optical imaging in underdeveloped countries
3.5.3.Opportunity
3.5.3.1.High market growth potential in emerging markets
3.5.4.Impact analysis
3.6.COVID-19 impact analysis on optical imaging market
CHAPTER 4:OPTICAL IMAGING MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Imaging systems
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.4.1.Optical imaging systems
4.2.4.1.1.Market size and forecast
4.2.4.2.Spectral imaging systems
4.2.4.2.1.Market size and forecast
4.3.Software
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Lenses
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Camera
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.6.Illumination systems
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
CHAPTER 5:OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA
5.1.Overview
5.1.1.Market size and forecast
5.2.Ophthalmology
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Oncology
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Cardiology
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Neurology
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:OPTICAL IMAGING MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals & clinics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Research laboratories
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Pharmaceuticals & biotechnology companies
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:OPTICAL IMAGING MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. optical imaging market, by product type
7.2.2.1.2.U.S. optical imaging market, by therapeutic area
7.2.2.1.3.U.S. optical imaging market, by end user
7.2.2.2.Canada
7.2.2.2.1.Canada optical imaging market, by product type
7.2.2.2.2.Canada optical imaging market, by therapeutic area
7.2.2.2.3.Canada optical imaging market, by end user
7.2.2.3.Mexico
7.2.2.3.1.Mexico optical imaging market, by product type
7.2.2.3.2.Mexico optical imaging market, by therapeutic area
7.2.2.3.3.Mexico optical imaging market, by end user
7.2.3.North America market size and forecast, by product type
7.2.4.North America market size and forecast, by therapeutic area
7.2.5.North America market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany optical imaging market, by product type
7.3.2.1.2.Germany optical imaging market, by therapeutic area
7.3.2.1.3.Germany optical imaging market, by end user
7.3.2.2.France
7.3.2.2.1.France optical imaging market, by product type
7.3.2.2.2.France optical imaging market, by therapeutic area
7.3.2.2.3.France optical imaging market, by end user
7.3.2.3.UK
7.3.2.3.1.UK optical imaging market, by product type
7.3.2.3.2.UK optical imaging market, by therapeutic area
7.3.2.3.3.UK optical imaging market, by end user
7.3.2.4.Italy
7.3.2.4.1.Italy optical imaging market, by product type
7.3.2.4.2.Italy optical imaging market, by therapeutic area
7.3.2.4.3.Italy optical imaging market, by end user
7.3.2.5.Spain
7.3.2.5.1.Spain optical imaging market, by product type
7.3.2.5.2.Spain optical imaging market, by therapeutic area
7.3.2.5.3.Spain optical imaging market, by end user
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe optical imaging market, by product type
7.3.2.6.2.Rest of Europe optical imaging market, by therapeutic area
7.3.2.6.3.Rest of Europe optical imaging market, by end user
7.3.3.Europe market size and forecast, by product type
7.3.4.Europe market size and forecast, by therapeutic area
7.3.5.Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan optical imaging market, by product type
7.4.2.1.2.Japan optical imaging market, by therapeutic area
7.4.2.1.3.Japan optical imaging market, by end user
7.4.2.2.China
7.4.2.2.1.China optical imaging market, by product type
7.4.2.2.2.China optical imaging market, by therapeutic area
7.4.2.2.3.China optical imaging market, by end user
7.4.2.3.Australia
7.4.2.3.1.Australia optical imaging market, by product type
7.4.2.3.2.Australia optical imaging market, by therapeutic area
7.4.2.3.3.Australia optical imaging market, by end user
7.4.2.4.India
7.4.2.4.1.India optical imaging market, by product type
7.4.2.4.2.India optical imaging market, by therapeutic area
7.4.2.4.3.India optical imaging market, by end user
7.4.2.5.South Korea
7.4.2.5.1.South Korea optical imaging market, by product type
7.4.2.5.2.South Korea optical imaging market, by therapeutic area
7.4.2.5.3.South Korea optical imaging market, by end user
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific optical imaging market, by product type
7.4.2.6.2.Rest of Asia-Pacific optical imaging market, by therapeutic area
7.4.2.6.3.Rest of Asia-Pacific optical imaging market, by end user
7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by therapeutic area
7.4.5.Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil optical imaging market, by product type
7.5.2.1.2.Brazil optical imaging market, by therapeutic area
7.5.2.1.3.Brazil optical imaging market, by end user
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia optical imaging market, by product type
7.5.2.2.2.Saudi Arabia optical imaging market, by therapeutic area
7.5.2.2.3.Saudi Arabia optical imaging market, by end user
7.5.2.3.South Africa
7.5.2.3.1.South Africa optical imaging market, by product type
7.5.2.3.2.South Africa optical imaging market, by therapeutic area
7.5.2.3.3.South Africa optical imaging market, by end user
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA optical imaging market, by product type
7.5.2.4.2.Rest of LAMEA optical imaging market, by therapeutic area
7.5.2.4.3.Rest of LAMEA optical imaging market, by end user
7.5.3.LAMEA market size and forecast, by product type
7.5.4.LAMEA market size and forecast, by therapeutic area
7.5.5.LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.CANON INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.CARL ZEISS FOUNDATION (CARL ZEISS MEDITEC AG)
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.4.CYLITE PTY LTD.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments
8.5.DANAHER CORPORATION (LEICA MICROSYSTEMS GMBH)
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.HEIDELBERG ENGINEERING GMBH (HEIDELBERG ENGINEERING INC.)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.KONINKLIJKE PHILIPS N.V
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.MICHELSON DIAGNOSTICS LTD.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.9.OPTOVUE, LTD.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments
8.10.TOPCON CORPORATION (TOPCON HEALTHCARE)
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02.OPTICAL IMAGING MARKET FOR IMAGING SYSTEMS, BY REGION, 2020-2030($MILLION)
TABLE 03.OPTICAL IMAGING MARKET FOR IMAGING SYSTEMS, BY TYPE, 2020–2030 ($MILLION)
TABLE 04.OPTICAL IMAGING MARKET FOR SOFTWARE, BY REGION, 2020-2030($MILLION)
TABLE 05.OPTICAL IMAGING MARKET FOR LENSES, BY REGION, 2020-2030($MILLION)
TABLE 06.OPTICAL IMAGING MARKET FOR CAMERA, BY REGION, 2020–2030 ($MILLION)
TABLE 07.OPTICAL IMAGING MARKET FOR ILLUMINATION SYSTEMS, BY REGION, 2020-2030($MILLION)
TABLE 08.OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 09.OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 10.OPTICAL IMAGING MARKET FOR ONCOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 11.OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 12.OPTICAL IMAGING MARKET FOR NEUROLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 13.OPTICAL IMAGING MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 14.OPTICAL IMAGING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 15.OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030($MILLION)
TABLE 16.OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY REGION, 2020-2030($MILLION)
TABLE 17.OPTICAL IMAGING MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2030 ($MILLION)
TABLE 18.OPTICAL IMAGING MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20.U.S. OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 21.U.S. OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 22.U.S. OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23.CANADA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 24.CANADA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 25.CANADA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26.MEXICO OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 27.MEXICO OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 28.MEXICO OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29.NORTH AMERICA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 30.NORTH AMERICA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 31.NORTH AMERICA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32.EUROPE OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 33.GERMANY OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 34.GERMANY OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 35.GERMANY OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36.FRANCE OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 37.FRANCE OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 38.FRANCE OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39.UK OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 40.UK OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 41.UK OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42.ITALY OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 43.ITALY OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 44.ITALY OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45.SPAIN OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 46.SPAIN OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 47.SPAIN OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48.REST OF EUROPE OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 49.REST OF EUROPE OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 50.REST OF EUROPE OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51.EUROPE OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 52.EUROPE OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 53.EUROPE OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 54.ASIA-PACIFIC OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55.JAPAN OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 56.JAPAN OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 57.JAPAN OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58.CHINA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 59.CHINA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 60.CHINA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61.AUSTRALIA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 62.AUSTRALIA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 63.AUSTRALIA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64.INDIA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 65.INDIA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 66.INDIA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67.SOUTH KOREA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 68.SOUTH KOREA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 69.SOUTH KOREA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73.ASIA-PACIFIC OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 74.ASIA-PACIFIC OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 75.ASIA-PACIFIC OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76.LAMEA OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 77.BRAZIL OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 78.BRAZIL OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 79.BRAZIL OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80.SAUDI ARABIA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 81.SAUDI ARABIA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 82.SAUDI ARABIA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83.SOUTH AFRICA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 84.SOUTH AFRICA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 85.SOUTH AFRICA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86.REST OF LAMEA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 87.REST OF LAMEA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 88.REST OF LAMEA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 89.LAMEA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 90.LAMEA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 91.LAMEA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 92.ABBOTT: COMPANY SNAPSHOT
TABLE 93.ABBOTT: OPERATING SEGMENTS
TABLE 94.ABBOTT: PRODUCT PORTFOLIO
TABLE 95.ABBOTT: KEY DEVELOPMENTS
TABLE 96.CANON: COMPANY SNAPSHOT
TABLE 97.CANON: OPERATING SEGMENTS
TABLE 98.CANON: PRODUCT PORTFOLIO
TABLE 99.CANON: KEY DEVELOPMENTS
TABLE 100.CARL ZEISS: COMPANY SNAPSHOT
TABLE 101.CARL ZEISS: PRODUCT SEGMENTS
TABLE 102.CARL ZEISS: PRODUCT PORTFOLIO
TABLE 103.CYLITE: COMPANY SNAPSHOT
TABLE 104.CYLITE: OPERATING BUSINESS SEGMENT
TABLE 105.CYLITE: PRODUCT PORTFOLIO
TABLE 106.CYLITE: KEY DEVELOPMENTS
TABLE 107.DANAHER: COMPANY SNAPSHOT
TABLE 108.DANAHER: PRODUCT SEGMENTS
TABLE 109.DANAHER: PRODUCT PORTFOLIO
TABLE 110.HEILDELBERG: COMPANY SNAPSHOT
TABLE 111.HEILDELBERG: PRODUCT SEGMENTS
TABLE 112.HEILDELBERG: PRODUCT PORTFOLIO
TABLE 113.HEILDELBERG: KEY DEVELOPMENTS
TABLE 114.PHILIPS: COMPANY SNAPSHOT
TABLE 115.PHILIPS: PRODUCT SEGMENTS
TABLE 116.PHILIPS: PRODUCT PORTFOLIO
TABLE 117.MICHELSON: COMPANY SNAPSHOT
TABLE 118.OPTOVUE: OPERATING BUSINESS SEGMENTS
TABLE 119.MICHELSON: PRODUCT PORTFOLIO
TABLE 120.OPTOVUE: COMPANY SNAPSHOT
TABLE 121.OPTOVUE: OPERATING BUSINESS SEGMENTS
TABLE 122.OPTOVUE: PRODUCT PORTFOLIO
TABLE 123.OPTOVUE: KEY DEVELOPMENTS
TABLE 124.TOPCON: COMPANY SNAPSHOT
TABLE 125.TOPCON: OPERATING SEGMENTS
TABLE 126.TOPCON: PRODUCT PORTFOLIO
TABLE 127.TOPCON: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.GLOBAL OPTICAL IMAGING MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.OPTICAL IMAGING SYSTEMS MARKET, 2020–2030 ($MILLION)
FIGURE 15.SPECTRAL IMAGING SYSTEMS MARKET, 2020–2030 ($MILLION)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR SOFTWARE, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR LENSES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR CAMERA, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR ILLUMINATION SYSTEMS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 28.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.ABBOTT: REVENUE SHARE BY REGION, 2020(%)
FIGURE 31.CANON: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.CANON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.CANON: REVENUE SHARE BY REGION, 2020(%)
FIGURE 34.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 37.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 40.TOPCON: NET SALES, 2019–2020 ($MILLION)
FIGURE 41.TOPCON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.TOPCON: REVENUE SHARE BY REGION, 2020 (%)
Optical imaging is awaited to observe higher adoption across several countries in the future, owing to increase in awareness related to its use across the globe. In addition, the market is exhibiting high growth rate, owing to surge in medical conditions, which require the use of optical imaging.
Moreover, surge in geriatric population that suffers from medical condition requiring the use of optical imaging drives the growth of market. Furthermore, rise in R&D activities related to use of optical imaging in breast cancer and other cancers is expected to fuel the growth during the forecast period.
North America acquires the major share in optical imaging market due to presence of key players. Hence, this leads to easy availability of optical imaging products, thereby augmenting the growth of market. However, Asia-Pacific is expected to offer remunerative growth opportunities during the forecast period, owing to gradual rise in adoption of optical imaging system.
A. The total market value of optical imaging market is $1,386.8 million in 2020.
A. The forcast period for optical imaging market is 2021 to 2030
A. The market value of optical imaging market in 2021 is $1,542.1 million.
A. The base year is 2020 in optical imaging market
A. Top companies such as Abbott Laboratories, Koninklijke Philips N.V., Canon Inc., Topcon Corporation, Carl Zeiss Meditec AG, Danaher Corporation (Leica Microsystems), and Headwall Photonics, Inc. held a high market position in 2020.
A. Imaging systems segment is the most influencing segment owing to increase in demand of imaging system owing to benefits of imaging systems provide over other imaging modalities such as non-invasive nature of optical imaging systems.
A. Rise in government initiatives to control visual impairment, and surge in geriatric population which is more prone to wide array of diseases such as neurology disorders, ophthalmic conditions, cardiovascular conditions and others. In addition, surge in prevalence of eye disorders such as glaucoma and cataract boost the growth of the market.
A. Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to number of initiatives and enhanced investments from governments for the overall research and development of advanced optical imaging systems.
A. Optical imaging is the technique for taking images of the internal body parts non-invasively.
A. Optical imaging makes use of light waves for creation of images of organs, tissues, and cells. For the generation of an optical image, various type of devices and systems are employed
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
